Agenda

Day 1 Jun 17, 2024

11:00 AM — 12:00 PM

Machine Learning and Simulations to Facilitate Clinical Trials

11:00 AM — 12:00 PM

The Intersection of Science, Ethics, and Participant Collaboration in Pediatric Rare Disease Product Development

2:15 PM — 3:15 PM

Innovative Approaches to the Design of Pediatric Development Programs: What’s New in the Use of Pediatric Extrapolation

2:15 PM — 3:15 PM

The Cost of Moving the Needle on Clinical Trial Representation: Strategies for Diversity Budget Planning and Resourcing

3:30 PM — 4:30 PM

Past, Present, and Future: How Industry and FDA are Handling the Evolving Clinical Trial Diversity Regulatory Landscape

Day 2 Jun 18, 2024

8:00 AM — 9:00 AM

Feasible Site Feasibility Assessments: Rethinking Business as Usual to Reduce Burden, Timelines, and Costs for Sustainability

10:00 AM — 11:00 AM

External Control Arms at Scale: Multicenter, Multisource Infrastructure for External Control Arms

10:00 AM — 11:00 AM

Improving Patient Access to Clinical Trials Through Decentralization and Flexible Design: Lessons from Oncology

10:00 AM — 11:00 AM

Targeting Shared Molecular Etiologies to Accelerate Drug Development for Rare Diseases

1:15 PM — 2:15 PM

The European Clinical Trials Environment Under the Accelerating Clinical Trials (ACT EU) Initiative: Two Years On

1:15 PM — 2:15 PM

The State of Clinical Trials in 2024: Are We Making the Grade?

3:15 PM — 4:15 PM

Enhancing Adoption of Innovative Approaches in Clinical Trials

3:15 PM — 4:15 PM

Practical Approaches and Resources to Optimize Advocacy Group - Industry Collaborations: An Update on the PALADIN Consortium

4:30 PM — 5:30 PM

Accelerating Innovation Through Design: Integrating Real-World Data into Clinical Trials

4:30 PM — 5:30 PM

Innovation, Agility, and Accessibility in Trial Execution: Collaboration Among Labs, Pharmacies, and Research Enablers

Day 3 Jun 19, 2024

8:00 AM — 9:00 AM

Have a Safe Trip: Clinical and Patient Alignment in Clinical Trials with Psychedelics

10:00 AM — 11:00 AM

Defining an Inclusive Clinical Trials Approach in Europe

1:15 PM — 2:15 PM

A Clinical Research Workforce in Crisis: Imperatives for a Sustainable Staffing Model

1:15 PM — 2:15 PM

Regulatory Considerations in Trial Design for Cell and Gene Therapies

3:15 PM — 4:15 PM

More than Meets the Eye: AI’s Potential to Identify Skin Manifestations of Internal Disease in Patients of Color

3:15 PM — 4:15 PM

Recruitment Optimization in Clinical Trials: Looking Towards an Adaptive Future

4:30 PM — 5:30 PM

Using Influencers to Recruit Hard-to-Engage Populations

Day 4 Jun 20, 2024

9:15 AM — 10:15 AM

The Impact of Racial Discrimination on the Patient Clinical Trial Experience

Have an account?

DIA 2024 Global Annual Meeting

Agenda

Be informed and stay engaged.